珠海联邦制药股份有限公司中山分公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
129
NMPA:129
Drug Approvals
Polyvinyl Alcohol Eye Drops
- Product Name
- 聚乙烯醇滴眼液
- Approval Number
- 国药准字H20253649
- Approval Date
- Mar 18, 2025
NMPA
Betamethasone Valerate and Neomycin Sulfate Cream
- Product Name
- 联邦倍新
- Approval Number
- 国药准字H20040492
- Approval Date
- Aug 27, 2024
NMPA
Sodium Hyaluronate Eye Drops
- Product Name
- 玻璃酸钠滴眼液
- Approval Number
- 国药准字H20040352
- Approval Date
- Aug 27, 2024
NMPA
Ibuprofen Sustained-release Capsules
- Product Name
- 布洛芬缓释胶囊
- Approval Number
- 国药准字H19983137
- Approval Date
- Jul 8, 2024
NMPA
Cefotaxime Sodium for Injection
- Product Name
- 注射用头孢噻肟钠
- Approval Number
- 国药准字H20023014
- Approval Date
- Jun 21, 2024
NMPA
Dextromethorphan Hydrobromide Oral Solution
- Product Name
- 氢溴酸右美沙芬口服液
- Approval Number
- 国药准字H20013199
- Approval Date
- Jun 21, 2024
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 13
- Next
Clinical Trials
No trials found
News
No news found